Aug 26, 2015
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.12 to $0.01.
The split itself did not change the total investment value.
Karo Pharma AB (publ) (KARBF) trades on the Other OTC in the Drug Manufacturers - Specialty & Generic industry.
Karo Pharma AB (publ) company overviewThe latest split shown was on August 26, 2015. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on August 26, 2015.
Already premium?